Search research articles
Contact Us
Filters
Showing results (291-300 of 303) with videos related to
Page
of 31
Sort By:
Breast Cancer Research and Treatment
|
February 18, 2017
Comprehensive genomic profiling of malignant phyllodes tumors of the breast
Sahar Nozad, Christine E Sheehan, Laurie M Gay, et al.
ACS Nano
|
May 11, 2013
Chemical gradients on graphene to drive droplet motion
Sandra C Hernández, Charlee J C Bennett, Chad E Junkermeier, et al.
Journal of Clinical Pathology
|
August 1, 2014
Next-generation sequencing of adrenocortical carcinoma reveals new routes to targeted therapies
J S Ross, K Wang, J V Rand, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 27, 2013
Advanced urothelial carcinoma: next-generation sequencing reveals diverse genomic alterations and targets of therapy
Jeffrey S Ross, Kai Wang, Rami N Al-Rohil, et al.
Bioresource Technology
|
July 29, 2010
The utility of Shewanella japonica for microbial fuel cells
Justin C Biffinger, Lisa A Fitzgerald, Ricky Ray, et al.
The Oncologist
|
February 25, 2014
New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencing
Jeffrey S Ross, Kai Wang, Laurie Gay, et al.
The American Journal of Surgical Pathology
|
January 15, 2014
Comprehensive genomic profiling of relapsed and metastatic adenoid cystic carcinomas by next-generation sequencing reveals potential new routes to targeted therapies
Jeffrey S Ross, Kai Wang, Janna V Rand, et al.
European Journal of Clinical Pharmacology
|
July 6, 2006
Case-control study on the association of upper gastrointestinal bleeding and nonsteroidal anti-inflammatory drugs in Japan
Choitsu Sakamoto, Kentaro Sugano, Shinichi Ota, et al.
The Oncologist
|
October 29, 2017
<i>ALK</i> Fusions in a Wide Variety of Tumor Types Respond to Anti-ALK Targeted Therapy
Jeffrey S Ross, Siraj M Ali, Omotayo Fasan, et al.
Science (New York, N.Y.)
|
June 9, 2012
dSarm/Sarm1 is required for activation of an injury-induced axon death pathway
Jeannette M Osterloh, Jing Yang, Timothy M Rooney, et al.
Page
of 31
Search research articles
Search
Showing results (291-300 of 303) with videos related to
Sort By:
Page
of 31
Breast Cancer Research and Treatment
|
February 18, 2017
Comprehensive genomic profiling of malignant phyllodes tumors of the breast
Sahar Nozad, Christine E Sheehan, Laurie M Gay, et al.
ACS Nano
|
May 11, 2013
Chemical gradients on graphene to drive droplet motion
Sandra C Hernández, Charlee J C Bennett, Chad E Junkermeier, et al.
Journal of Clinical Pathology
|
August 1, 2014
Next-generation sequencing of adrenocortical carcinoma reveals new routes to targeted therapies
J S Ross, K Wang, J V Rand, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 27, 2013
Advanced urothelial carcinoma: next-generation sequencing reveals diverse genomic alterations and targets of therapy
Jeffrey S Ross, Kai Wang, Rami N Al-Rohil, et al.
Bioresource Technology
|
July 29, 2010
The utility of Shewanella japonica for microbial fuel cells
Justin C Biffinger, Lisa A Fitzgerald, Ricky Ray, et al.
The Oncologist
|
February 25, 2014
New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencing
Jeffrey S Ross, Kai Wang, Laurie Gay, et al.
The American Journal of Surgical Pathology
|
January 15, 2014
Comprehensive genomic profiling of relapsed and metastatic adenoid cystic carcinomas by next-generation sequencing reveals potential new routes to targeted therapies
Jeffrey S Ross, Kai Wang, Janna V Rand, et al.
European Journal of Clinical Pharmacology
|
July 6, 2006
Case-control study on the association of upper gastrointestinal bleeding and nonsteroidal anti-inflammatory drugs in Japan
Choitsu Sakamoto, Kentaro Sugano, Shinichi Ota, et al.
The Oncologist
|
October 29, 2017
<i>ALK</i> Fusions in a Wide Variety of Tumor Types Respond to Anti-ALK Targeted Therapy
Jeffrey S Ross, Siraj M Ali, Omotayo Fasan, et al.
Science (New York, N.Y.)
|
June 9, 2012
dSarm/Sarm1 is required for activation of an injury-induced axon death pathway
Jeannette M Osterloh, Jing Yang, Timothy M Rooney, et al.
Page
of 31